why choose us

First received: August 19, 2024

Clinical Trial: Stratification for F-L Therapy After LT

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Liver Transplantation

Study Type: OBSERVATIONAL


Official Title: Stratification for Efficacy of Adjuvant FOLFOX Plus Lenvatinib After Liver Transplantation for Hepatocellular Carcinoma in Recurrence Prevention

Brief Summary: Objective: To stratify recipients who underwent adjuvant FOLFOX plus lenvatinib (F-L) therapy following liver transplantation (LT) for hepatocellular carcinoma and provide guidance for clinical adjuvant therapy.Methods: Liver recipients in the Shulan (Hangzhou) Hospital from January, 2017 to December, 2021, including 106 in the F-L therapy group and 229 in the non-adjuvant (N-A) therapy group were included in the analysis.A 1:1 propensity score matching (PSM) analysis was performed to minimize group…

Read more